Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr 15;2009(2):CD006341.
doi: 10.1002/14651858.CD006341.pub2.

Interventions for apathy after traumatic brain injury

Affiliations

Interventions for apathy after traumatic brain injury

Amanda Lane-Brown et al. Cochrane Database Syst Rev. .

Abstract

Background: Apathy is a deficiency in overt behavioural, emotional and cognitive components of goal-directed behaviour. It is a common occurrence after traumatic brain injury (TBI), with widespread impact. We have systematically reviewed studies examining the effectiveness of interventions for apathy in the TBI population.

Objectives: To investigate the effectiveness of interventions for apathy in adults who have sustained a TBI. This was evaluated by changes in behavioural, cognitive and emotional measures of apathy.

Search strategy: We searched the following databases up to January 2008: CENTRAL (The Cochrane Library 2008, Issue 1), Database of Abstracts of Reviews of Effects, ACP Journal Club, MEDLINE (1950 to Jan 2008), EMBASE (1980 to Jan 2008), PsycINFO (1806 to Jan 2008), CINAHL (1982 Jan 2008), PsycBITE, AMED (1985 to Jan 2008), www.controlled-trials.com, www.clinicaltrials.gov and www.actr.org.au.The Cochrane Injuries Group's Specialised Register was searched to Jan 2009. Additionally, we examined key conference proceedings and reference lists of included trials to identify further studies meeting the inclusion criteria.

Selection criteria: Randomised controlled trials (RCTs) of interventions specifically targeting apathy for people with TBI.

Data collection and analysis: Two authors (ALB and RLT) independently assessed studies for inclusion. We rated the methodological quality of included studies and extracted data.

Main results: We identified one trial that satisfied the inclusion criteria for this review. This trial (N = 21) showed that cranial electrotherapy stimulation (CES) decreased inertia, which is a component of apathy, while no changes were seen in the sham treatment or no treatment control groups. Given that no between-group analysis was reported, it was not possible to determine if the CES treatment group improved significantly more than the control group.

Authors' conclusions: No evidence was provided to support the use of CES treatment for inertia, a component of apathy. Between-group statistical analyses were not conducted and it was therefore not possible to determine the efficacy of the treatment relative to no treatment or sham treatment. Results regarding the effectiveness of treatment can only be inferred, and this evidence is based on only one trial with a small sample size. More randomised controlled trials evaluating different ways of treating apathy would be valuable. Trials should have larger sample sizes and use rigorous research designs and statistical analyses appropriate for examining between-group differences.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Update of

References

References to studies included in this review

Smith 1994 {published data only (unpublished sought but not used)}
    1. Smith RB, Tiberi A, Marshall J. The use of cranial electrotherapy stimulation in the treatment of closed‐head‐injured patients. Brain Injury 1994;8(4):357‐61. - PubMed

References to studies excluded from this review

Chapman 2004 {published data only}
    1. Chapman SB, Weiner MF, Rackley A, Hynan LS, Zientz J. Effects of cognitive‐communication stimulation for Alzheimer's disease patients treated with Donepezil. Journal of Speech, Language, and Hearing Research 2004;47:1149‐63. - PubMed
Cummings 2001 {published data only}
    1. Cummings JL, Nadel A, Masterman D, Cyrus, PA. Efficacy of Metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 2001;14:101‐8. - PubMed
Danielczyk 1988 {published data only}
    1. Danielczyk W, Simanyi B, Forette F, Orgogozo J, Pere J, Hugonot L, et al. CBM 36‐733 (2 methyl‐alpha‐ergokryptine) in primary degenerative dementia: Results of a European multicentre trial. International Journal of Geriatric Psychiatry 1988;3:107‐14.
Feldman 2003 {published data only}
    1. Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, et al. Efficacy of Donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Journal of the American Geriatrics Society 2003;51:737‐44. - PubMed
Gauthier 2002 {published data only}
    1. Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, et al. Efficacy of Donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. International Psychogeriatrics 2002;14(4):389‐404. - PubMed
Gelinas 2000 {published data only}
    1. Gelinas I, Gauthier S, Cyrus P. Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living. Journal of Geriatric Psychiatry and Neurology 2000;13(1):9‐16. - PubMed
Graff 2006 {published data only}
    1. Graff MJ, Vernooij‐Dassen MJM, Zajec J, Olde‐Rikkert MGM, Hoefnagels WH, Dekker J. How can occupational therapy improve the daily performance and communication of an older patient with dementia and his primary caregiver?. Dementia: The International Journal of Social Research and Practice 2006;5(4):503‐32.
Harris 2005 {published data only}
    1. Harris K, Reid D. The influence of virtual reality play on children's motivation. Canadian Journal of Occupational Therapy 2005;72(1):21‐9. - PubMed
Hozumi 1996 {published data only}
    1. Hozumi S, Hori H, Okawa M, Hishikawa Y, Sato K. Favorable effect of transcranial electrostimulation on behavior disorders in elderly patients with dementia: a double‐blind study. International Journal of Neuroscience 1996;88(1‐2):1‐10. - PubMed
Kaufer 1998 {published data only}
    1. Kaufer D. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 1998;9(Suppl 2):8‐14. - PubMed
Lanctot 2002 {published data only}
    1. Lanctot KL, Herrmann N, Reekum R, Eryavec G, Naranjo CA. Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease. International Journal of Geriatric Psychiatry 2002;17(6):531‐41. - PubMed
Lebert 1998 {published data only}
    1. Lebert F, Pasquier F, Souliez L, Petit H. Tacrine efficacy in Lewy Body dementia. International Journal of Geriatric Psychiatry 1998;13(8):516‐9. - PubMed
Newburn 2005 {published data only}
    1. Newburn G, Newburn D. Selegiline in the management of apathy following traumatic brain injury. Brain Injury 2005;19(2):149‐54. - PubMed
Olazaran‐Rodriguez 2004 {published data only}
    1. Olazaran‐Rodriguez J, Cruz‐Orduna I, Jimenez‐Martin I. Donepezil therapy in patients with vascular and post‐traumatic cognitive impairment: some clinical observations [Tratamiento con donepecilo en pacientes con deterioro cognitivo vascular y postraumatico: observaciones clinicas]. Revista de Neurologia 2004;38(10):938‐43. - PubMed
Politis 2004 {published data only}
    1. Politis AM, Vozzella S, Mayer LS, Onyike CU, Baker AS, Lyketsos CG. A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long‐term care. International Journal of Geriatric Psychiatry 2004;19(11):1087‐94. - PubMed
Powell 1996 {published data only}
    1. Powell JH, Al‐Adawi S, Morgan J, Greenwood RJ. Motivational deficits after brain injury: effects of bromocriptine in 11 patients. Journal of Neurology, Neurosurgery and Psychiatry 1996;60:416‐21. - PMC - PubMed
Swanberg 2007 {published data only}
    1. Swanberg MM. Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Disease and Associated Disorders 2007;21(2):164‐6. - PubMed
Tenovuo 2005 {published data only}
    1. Tenovuo O. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury ‐ clinical experience in 111 patients. Progress in Neuro‐Psychopharmacology and Biological Psychiatry 2005;29(1):61‐7. - PubMed
van Reekum 1995 {published data only}
    1. Reekum R, Bayley M, Garner S, Burke IM, Fawcett S, Hart A, et al. N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Injury 1995;9(1):49‐53. - PubMed
von Cramon 1991 {published data only}
    1. Cramon D, Matthes‐von Cramon G, Mai N. Problem‐solving deficits in brain‐injured patients: a therapeutic approach. Neuropsychological Rehabilitation 1991;1(1):45‐64.

References to studies awaiting assessment

Morikawa 2000 {published data only}
    1. Morikawa, M. Successful treatment using low‐dose Carbamazepine for a patient of personality change after diffuse brain injury. Japanese Journal of Psychopharmacology 2000;20(4):149‐153. - PubMed
Timsit‐Berthier 1980 {published data only}
    1. Timsit‐Berthier M, Mantanus H, Jacques MC, Legros JJ. Use of lysine‐vasopressine in the treatment of post‐traumatic amnesia. Acta Psychiatrica Belgica 1980;80(5):728‐747. - PubMed

Additional references

American Congress of Rehabilitation Medicine 1995
    1. American Congress of Rehabilitation Medicine. Recommendations for use of uniform nomenclature pertinent to patients with severe alterations in consciousness. Archives of Physical Medicine and Rehabilitation 1995;76:205‐9. - PubMed
Baker 2001
    1. Baker R, Bell S, Baker E, Gibson S, Holloway J, Pearce R, et al. A randomized controlled trial of the effects of multi‐sensory stimulation (MSS) for people with dementia. British Journal of Clinical Psychology 2001;40(1):81‐96. - PubMed
Crepeau 1997
    1. Crepeau F, Scherzer P, Belleville S, Desmarais G. A qualitative analysis of central executive disorders in a real‐life work situation. Neuropsychological Rehabilitation 1997;7:147‐65.
Deb 2004
    1. Deb S, Crownshaw T. The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury. Brain Injury 2004;18(1):1‐31. - PubMed
Evans 1998
    1. Evans JJ, Emslie H, Wilson B. External cueing systems in the rehabilitation of executive impairments of action. Journal of the International Neuropsychological Society 1998;4:399‐408. - PubMed
Finset 2000
    1. Finset A, Andersson S. Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location. Brain Injury 2000;14(10):887‐905. - PubMed
Fitzsimmons 2003
    1. Fitzsimmons S, Buettner LL. A therapeutic cooking program for older adults with dementia: effects on agitation and apathy. American Journal of Recreation Therapy 2;4:23‐33.
Glenn 2002
    1. Glenn MB, Burke DT, O'Neil‐Pirozzi T, Goldstein R, Jacob L, Kettell J. Cutoff score on the apathy evaluation scale in subjects with traumatic brain injury. Brain Injury 2002;16(6):509‐16. - PubMed
Higgins 2002
    1. Higgins JPT, Thompson SG. Quantifying heterogeneity in meta‐analysis. Statistics in Medicine 2002;21:1539‐58. - PubMed
Higgins 2005
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library. Chichester, UK: John Wiley & Sons Ltd, 2005; Vol. Issue 3.
Higgins 2008
    1. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.0.0. The Cochrane Collaboration, 2008.
Kant 1998
    1. Kant R, Duffy JD, Pivovarnik A. Prevalence of apathy following head injury. Brain Injury 1998;12(1):87‐92. - PubMed
Kant 2002
    1. Kant R, Smith‐Seemiller L. Assessment and treatment of apathy syndrome following head injury. NeuroRehabilitation 2002;17:325‐31. - PubMed
Kay 1993
    1. Kay T, Adams R, Anderson T, Berrol S, Cicerone K, Dahlberg C, et al. Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation 1993;8(3):86‐7.
Levy 1998
    1. Levy M, Cummings J, Fairbanks L, Masterman D, Miller B, Craig A, et al. Apathy is not depression. Journal of Neuropsychiatry and Clinical Neurosciences 1998;10(3):314‐9. - PubMed
Luria 1973
    1. Luria AR. The Working Brain. Middlesex: The Penguin Press, 1973.
Maher 2003
    1. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomised controlled trials. Physical Therapy 2003;83(8):713‐21. - PubMed
Marin 1990
    1. Marin R. Differential diagnosis and classification of apathy. American Journal of Psychiatry 1990;147(1):22‐30. - PubMed
Marin 1991
    1. Marin R. Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry 1991;3(3):243‐54. - PubMed
Marin 1991b
    1. Marin R, Firiniciogullari S, Biedrzycki RC. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Research 1991;38:143‐62. - PubMed
Marin 1996
    1. Marin R. Apathy and related disorders of diminished motivation. In: Dickstein L, Riba M editor(s). Review of Psychiatry. Washington, DC: American Psychiatric Press, 1996:205‐42.
Marin 2005
    1. Marin R, Chakravorty M. Disorders of diminished motivation. In: Silver JM, McAllister TW, Yudofsky SC editor(s). Textbook of traumatic brain injury. Washington, DC: American Psychiatric Publishing, Inc, 2005:337‐52.
Marin 2005b
    1. Marin R, Wilkosz P. Disorders of diminished motivation. Journal of Head Trauma Rehabilitation 2005;20(4):377‐88. - PubMed
Marsh 1998
    1. Marsh NV, Kersel DA, Havill JH, Sleigh JW. Caregiver burden at 1 year following severe traumatic brain injury. Brain Injury 1998;12(12):1045‐59. - PubMed
McMillan 1999
    1. McMillan T, Sparkes C. Goal planning and neurorehabilitation: The Wolfson Neurorehabilitation Centre approach. Neuropsychological Rehabilitation 1999;9(3/4):241‐51.
Perdices 2006
    1. Perdices M, Schultz R, Tate R, McDonald S, Togher L, Savage S, et al. The evidence base of neuropsychological rehabilitation in acquired brain impairment (ABI): how good is the research?. Brain Impairment 2006;7(2):119‐32.
Prigatano 1992
    1. Prigatano GP. Personality disturbances associated with traumatic brain injury. Journal of Consulting and Clinical Psychology 1992;3:360‐8. - PubMed
Purdie 1997
    1. Purdie H. Music therapy with adults who have traumatic brain injury and stroke. British Journal of Music Therapy 1997;11(2):45‐50.
Review Manager 5 [Computer program]
    1. The Nordic Cochrane Centre. Review Manager. Version 5.0. Copenhagen: The Cochrane Collaboration, 2008.
Roth 2007
    1. Roth R, Flashman L, McAllister T. Apathy and its treatment. Current Treatment Options in Neurology 2007;9:363‐70. - PubMed
Stuss 2000
    1. Stuss DT, Reekum R, Murphy KJ. Differentiation of states and causes of apathy. In: Borod J editor(s). The Neuropsychology of Emotion. Oxford: Oxford University Press, 2000:340‐63.
Tate 2004
    1. Tate RL, Perdices M, McDonald S, Togher L, Moseley A, Winders K, et al. Development of a database of rehabilitation therapies for the psychological consequences of acquired brain impairment. Neuropsychological Rehabilitation 2004;14(5):517‐34.
Wilson 2002
    1. Wilson B, Evans J, Keohane C. Cognitive rehabilitation: a goal planning approach. Journal of Head Trauma Rehabilitation 2002;17(6):542‐55. - PubMed

Publication types